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SUMMARY
Migrants from Java arrive in hyperendemic Papua, Indonesia lacking exposure to endemic
malaria. We evaluated records of evacuation to hospital with a diagnosis of severe malaria from
a transmigration village in northeastern Papua. During the first 30 months, 198 residents with
severe disease were evacuated (7.5 evacuations/100 person-years). During this period the risk
of evacuation for adults (>15 years of age) was 2.8. (95% CI=2.1–3.8; P<0.0001) relative to
children, despite apparently equal exposure to risk of infection. Relative risk (RR) for adults
was greatest during the first 6 months (RR>16; 95% CIo2.0–129; P=0.0009), and diminished
during the second 6 months (RR=9.4; 95% CI=2.7–32.8; P<0.0001) and the third 6 months
(RR=3.7; 95% CI=1.7–7.9; P=0.0004). During the next two 6-month intervals, the RR for
adults was 1.6 and 1.5 (95% CI range 0.8–2.6; P<0.18). Adults lacking chronic exposure were
far more likely to progress to severe disease compared to children during initial exposure, but
not after chronic exposure to infection.
INTRODUCTION
Adults having lifelong exposure to holoendemic ma-
laria caused by Plasmodium falciparum rarely suffer
serious disease despite apparently continuous infec-
tion [1–3]. In contrast, infants and young children
with malaria in these areas suffer relatively high rates
of life-threatening disease, manifest as severe anaemia,
respiratory distress, lactic acidosis and cerebral ma-
laria [4–6]. Very young children in holoendemic Sub-
Saharan Africa account for most of the 1–2 million
deaths caused by malaria each year [7]. Nonetheless,
severe malaria is not exclusively a disease of children;
endemic and epidemic malaria in Asia and the
Americas afflict residents of all ages, as do infections
among travellers [8–10]. Susceptibility to severe dis-
ease among otherwise healthy non-immune people is
widely considered uniform across age groups [11, 12].
This view stems largely from the widely held notion
that protection from severe disease arises as the
cumulative product of heavy exposure to infection
through childhood [13–15].
Intrinsic differences between the immune systems
of children and adults, distinct from the extrinsic
factor of cumulative exposure to infection, may also
impact the immune response to P. falciparum. These
differences may be strictly developmental [16, 17] or
established by exposure to non-P. falciparum antigens
experienced through the normal course of life [18].
Intrinsic age-related changes to the immune system
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may be the basis of profoundly distinct immune re-
sponses to repeated infection by P. falciparum, and
thus significantly affect the clinical course and conse-
quence of infection. The relative susceptibility of chil-
dren in heavily endemic areas may be driven primarily
by intrinsic factors rather than by insufficient exposure
to infection. We previously conducted epidemiologi-
cal studies of Javanese migrants to hyperendemic
Indonesian Papua that supported this view [19, 20].
Defining the cellular and molecular basis of age-
dependent clinical immunity may guide approaches to
inducing adult-like protection from P. falciparum in
children [21, 22].
Discerning intrinsic age-related differences in sus-
ceptibility to primary infection by P. falciparum re-
quires access to human populations abruptly exposed
to high risk of infection. Most published reports of
malaria epidemics fail to communicate sufficient detail
to estimate age-specific risks of severe disease. Among
the few that do, a pattern of exaggerated adult suscep-
tibility emerges [23, 24]. Studies of non-immune trav-
ellers with malaria reveal a similar pattern [25–28].
This laboratory conducted a retrospective analysis of
age-related risk of severe disease caused by malaria
among non-immune Javanese migrants to Papua [29].
The risk of emergency evacuation to hospital with a
clinical diagnosis of malaria among adults was 2.7
(95% CI=1.9–3.8) relative to children during the first
6 months of exposure. This report describes a similar
study in another migration settlement in the same
region.
MATERIALS AND METHODS
Study design
In this retrospective cohort study, records of emerg-
ency evacuation froma remote village to tertiaryhealth
care facilities with a provisional diagnosis of malaria
were reviewed for the period when the village first
opened in September 1997 to February 2000. The
analysis focused on the risk of evacuation for malaria
among adults (age>15 years) relative to children (age
f15 years). Monthly estimates of age-specific risk
were derived from the reported number of evacuations
divided by estimated monthly total population at risk
derived from concurrent annual census data.
Study site
The village of Arso XIV (Wulukubun) in northeastern
Indonesian Papua (formerly known as Irian Jaya)
served as the study site. Malaria caused by P. falci-
parum and P. vivax is hyper- to holoendemic and
transmitted by all three established species of the
Anopheles punctulatus complex : An. punctulatus, An.
koliensis and An. farauti. Exposure to biting anophe-
lines occurs in and around homes between dusk and
dawn [30, 31]. Attack rates for malaria in the Arso
region have typically ranged between 0.5 and 4 infec-
tions/person-year [32–35]. Cross-sectional studies in
similar villages revealed relatively uniform prevalence
of parasitemia across age groups during the first year
of exposure [20]. In a recent study in a similar setting
we followed 243 migrants to their first infection by
P. falciparum or P. vivax and found no difference in
the attack rates between adults and children [36]. We
know of no age-related risk factor for exposure to
infection in this setting.
Study population
Residents of Arso XIV came predominantly from
Java (83% of residents), where the risk of malaria has
been less than 1 infection per 10000 person-years for
most areas since the mid-1960s [37, 38]. Melanesian
Papuan people native to the area constituted most of
the remainder (16% of residents). Age-specific census
data for Arso XIV reported in January of each year
were available for 1998, 1999 and 2000. The total
numbers of residents on these dates were 502, 1411
and 1463. Table 1 lists the available census data and
the relative numbers of children (f15 years old) and
adults (>15 years old).
Emergency evacuation
A government nurse delivered health care through
a permanent health post located in the centre of the
village. Serious ailments required referral to a re-
gional clinic or hospitals 15 and 35 km distant. In
general, only perceived life-threatening clinical con-
ditions prompted medical evacuation of patients. For
malaria, a routine illness in the new settlement, only
severe disease marked by delirium or unconsciousness
would prompt evacuation. The referral required the
Table 1. Annual census reports for Arso XIV
Year
Children
(<16 years)
Adults
(>15 years)
1998 346 156
1999 571 840
2000 623 840
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written permission of the civil authorities and thereby
created an administrative record of emergency evacu-
ations. The record of evacuation included date, name,
age, gender, address, and clinical diagnosis. This office
also maintained records of complete censuses reported
in January of each year. In April 2000 we visited Arso
XIV and obtained these records.
Statistical analysis
Incidence of evacuation to the clinic or hospital with
a recorded diagnosis of malaria constituted the pri-
mary outcome of interest and served as the indicator
of severe disease. Age-specific person-time at risk was
estimated for each month on the basis of census
data reported in January of 1998, 1999 and 2000. We
divided the population between children (f15 years)
and adults (>15 years) and extrapolated a monthly
estimate of each by extrapolating between the Jan-
uary census data assuming a steady rate of change
in population over the year. Table 1 lists the available
census data. The estimated respective totals of chil-
dren or adults for each month divided by 12 gave
person-years at risk for thatmonth. Themonthly num-
ber of child or adult evacuations divided by person-
years at risk gave the incidence of evacuation in events
per person-year. We multiplied this estimate by 100 to
yield events per 100 person-years. The risk of evacu-
ated malaria among adults relative to children was
calculated. We divided the 30-month period of ob-
servation into five chronological periods of 6 months
each (designated I–V). The sum of monthly evacu-
ations and person-time at risk over the interval was
used to calculate relative risk and 95% confidence
interval (CI) using Epi-Info 2000 (version 1.0, Centers
for Disease Control, Atlanta, GA, USA).
RESULTS
Malaria risk
Figure 1 illustrates the number of clinical cases of
malaria recorded by the village nurse in the Arso XIV
health post. During interval I this number climbed to
asmany as 80 cases/month, but fell to zero early during
interval II. Malaria peaked again to 126 cases/month
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Fig. 1. Monthly number of malaria treatments recorded in the health post at Arso XIV (m, dotted line) and the monthly
incidence of emergency evacuations with a clinical diagnosis of malaria recorded at the village administrative centre ($, solid
line). Roman numerals at foot of graph delineate intervals of 6 months used to estimate relative risk (Table 2).
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in this interval. During interval III malaria peaked to
163 cases/month. Late during interval IV the number
of recorded malaria cases in the village increased
sharply to a high of 554 cases. This prompted inter-
vention by the health authorities (mass drug admin-
istration using chloroquine and primaquine and
spraying of residual insecticides in homes). The re-
cording of routine malaria cases by the nurse did not
appear consistent and were not applied to estimates
of risk of medical evacuation.
Evacuated malaria
Microscopic confirmation of clinical diagnoses of
malaria was not available at the village health post.
However, review of the records at the secondary
and tertiary health-care clinics and hospital that re-
ceived the evacuated patients allowed review of diag-
noses and outcomes among 69 of the 198 evacuations
logged. Malaria microscopy results were recovered
from 28 of these cases and all were positive. Among
the 69 cases reviewed, death was recorded as the out-
come for 6 (9% case fatality rate). Among the dead,
only one patient was less than 30 years of age; an
18-year-oldwoman in her 36thweek of pregnancy. The
odds ratio for death in this sample of 69 patients was
10.0 (95% CI=1.01–242; P=0.026) for those over 30
(n=26) compared to patients under 30 (n=43).
Figure 1 also illustrates the monthly incidence of
evacuation with a clinical diagnosis of malaria. Inci-
dence of evacuation generally followed the pattern of
recorded malaria treatments in the village. The peak
monthly incidence of malaria evacuation occurred in
May 1999 with 20/100 person-years. A total of 198
people were evacuated to the clinic or hospital during
the 30 months of observation. The estimated total
person-time at risk during this periodwas 2637 person-
years. The overall incidence of evacuation was 198
events per 2637 person-years (7.5/100 person-years).
Figure 2 illustrates age-specific monthly incidence
of evacuated malaria. The incidence of evacuation
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Fig. 2.Monthly incidence of emergency evacuation with a clinical diagnosis of malaria recorded at the village administrative
centre for children (m, dotted line) and adults ($, solid line) in Arso XIV. Roman numerals at foot of graph delineate
intervals of 6 months used to estimate relative risk (Table 2).
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for adults exceeded that for children at virtually all
monthly points. Overall, 142 adults and 53 children
were evacuated over the 30-month period, with esti-
mated person-time at risk being 1287 and 1350 person-
years, respectively. The 30-month risk of evacuation
in adults relative to children was 2.8 (95% CI=2.0–
3.9; P<0.0001). Table 2 summarizes interval specific
risk of evacuation among adults relative to children.
During the first interval eight adults and no children
were evacuated. The incidence of evacuation for
adults was 9.4/100 person-years and for children was
<0.58/100 person-years (RR>16, 95% CI>2–129;
P<0.0001). During the second interval, 14 adults and
3 children were evacuated to hospital or clinic (RR=
9.4, 95% CI=2.7–32.8; P<0.0001). During the third
interval, 25 adults and 9 children were evacuated to
hospital or clinic (RR=3.7, 95% CI=1.7–7.9; P<
0.001). The remaining two intervals each showed a
risk of 1.6 and 1.5 for adults relative to children (mar-
ginally significant at P=0.05, and insignificant at
P=0.18, see Table 2).
DISCUSSION
An analysis of records of emergency evacuation with
a clinical diagnosis of malaria revealed Javanese
adults abruptly exposed to endemic malaria in north-
eastern Papua, Indonesia were at much greater risk of
severe disease compared to children. These findings
corroborated essentially similar outcomes in a dif-
ferent village in the same region [29]. This pattern
accords with age-related susceptibility among non-
immune people in the setting of epidemic malaria
[23, 24] or travellers [25–28]. We considered intrinsic
age-related differences in the immune systems of chil-
dren and adults the most likely explanation for the
apparent susceptibility of adults to onset of severe
disease caused by primary exposure to P. falciparum.
Age-related differences in risk of infection represent
an unlikely alternative explanation. We rejected this
explanation in light of well-characterized patterns of
risk of infection in the region. Arso XIV, like Arso
PIR IV [29], was an agrarian community of cleared
fields surrounded by dense forest. The anopheline vec-
tors of the region prefer the open, sun-lit habitats
created by these settlements, where virtually all feed-
ing and breeding by these mosquitoes occurs [30, 31].
These vectors avoid the forest, and most residents
do not wander into it, especially during the first year
when they must establish sustenance and cash crops
within the cleared area of the village. Cross-sectional
studies in essentially identical settings revealed rela-
tively uniform prevalence of infection across age
groups during the first year of residence [22]. A recent
longitudinal study of Javanese migrants in a nearby
settlement revealed virtually identical incidence den-
sity of infection by both P. falciparum and P. vivax
among adults and children during their first year
in the region [36]. The children and adults settling
into rural areas of northeastern Papua such as Arso
XIV apparently experience equal exposure to risk of
infection.
Other potentially confounding factors were con-
sidered as the basis of the observed differences in
susceptibility between children and adults. Although
the same individual served as the health post nurse
during the entire study period, her relative inexperi-
ence in this setting during the early months may
have resulted in a relatively low clinical threshold
for evacuation. However, we doubt such a tendency
would explain the apparently higher risk among
adults. A presumably greater sensitivity to the health
of children should have created a bias in the opposite
direction, i.e. higher risk of evacuation for children.
Another potential confounder may have been greater
likelihood of early treatment among children. The
Table 2. Interval-specific risk for emergency evacuation in adults relative to children
Interval
Person-years Evacuations
Children Adults Children Adults Relative risk 95% CI P value*
I 172 85 0 8 16.2 2.0–129 0.0009
II 281 139 3 14 9.4 2.7–32.8 <0.0001
III 365 275 9 25 3.7 1.7–7.9 0.0004
IV 286 429 23 56 1.6 1.0–2.6 0.051
V 246 359 18 39 1.5 0.8–2.6 0.179
Total 1350 1287 53 142 2.8 2.1–3.8 <0.0001
* Two-tailed.
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typically stoic adults may have been more likely to
defer treatment compared to children, but the avail-
able evidence suggests essentially equally frequent
consumption of antimalarials. We found no basis to
attribute the extraordinarily high risk among adults
to these potential confounding factors.
Studies of non-immune people exposed to P. falci-
parum in other settings also suggest adults being sig-
nificantly more susceptible to severe disease. Among
travellers with falciparum malaria hospitalized and
treated in North America or Europe, higher age has
consistently emerged as a significant risk factor for
severe disease and death [25–28]. Higher hospitaliz-
ation and death rates among adults in the setting of
epidemic malaria have been reported [23, 24]. How-
ever, risk of severe disease among adults in popu-
lations with chronic exposure to relatively low risk
of malaria, e.g. along the Thai–Burma border [39]
or in urban areas of Sub-Saharan Africa [40], tends
to be appreciably lower compared to young children.
We believe the age-dependent exacerbation of risk
of severe disease may appear only in adults and chil-
dren who are not chronically exposed to infection by
P. falciparum. Indeed, exacerbated risk of severe dis-
ease among adults rapidly waned (Table 2 and refer-
ence [29]) among the Javanese migrants transitioning
from acute to chronic exposure.
Severe, life-threatening malaria caused by P. falci-
parum has been linked to the release of pro-inflam-
matory cytokines, especially tumour necrosis factor
(TNF) [40–43]. The basis of adult susceptibility to
severe disease caused by primary infection with P.
falciparum may lie in the production of inordinately
high levels of pro-inflammatory cytokines like TNF.
Clinical studies correlated TNF levels with disease
severity in European adults [44, 45]. Studies in a var-
iety of animal models utilizing primary exposure to
infectious agents or endotoxin demonstrated an often
sharply greater susceptibility to severe disease among
mature vs. immature animals [46, 47].
In summary, this study supports the hypothesis that
intrinsic age-related differences between the immune
systems of children and adults may drive distinct in-
nate immune responses and clinical outcomes. The
adult immune response to first infection apparently
renders them more likely to progress to severe disease
in the absence of prompt diagnosis and effective
treatment. Non-immune adults may mount a poten-
tially harmful immune response driven by innate or
cross-reactive acquired immune effectors. This effect
largely vanished with continued exposure to infection.
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